Ignite Creation Date:
2025-12-24 @ 7:45 PM
Ignite Modification Date:
2025-12-25 @ 5:23 PM
Study NCT ID:
NCT05732103
Status:
RECRUITING
Last Update Posted:
2025-09-22
First Post:
2023-01-24
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Study of CTX-712 in Relapsed/Refractory Acute Myeloid Leukemia and Higher Risk Myelodysplastic Syndromes
Sponsor:
Chordia Therapeutics, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-04-25
Start Date Type:
ACTUAL
Primary Completion Date:
2028-06
Primary Completion Date Type:
ESTIMATED
Completion Date:
2029-02
Completion Date Type:
ESTIMATED
First Submit Date:
2023-01-24
First Submit QC Date:
None
Study First Post Date:
2023-02-16
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-09-17
Last Update Post Date:
2025-09-22
Last Update Post Date Type:
ESTIMATED